|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/55 | |
| A61K 38/46 | |||
| A61P 19/08 | |||
| C12N 15/85 | |||
| C12N 5/10 | |||
| C12N 9/16 |
| (11) | Patento numeris | 2158319 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08757088.3 |
| Europos patento paraiškos padavimo data | 2008-05-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-03-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-12-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2008/000923 |
| Data | 2008-05-12 |
| (87) | Numeris | WO 2008/138131 |
| Data | 2008-11-20 |
| (30) | Numeris | Data | Šalis |
| 917589 P | 2007-05-11 | US |
| (72) |
CRINE, Philippe, CA
BOILEAU, Guy, CA
LOISEL, Thomas, P., CA
LEMIRE, Isabelle, CA
LEONARD, Pierre, CA
HEFT, Robert, CA
LANDY, Hal, US
|
| (73) |
Enobia Pharma Inc.,
2901, rue Rachel Est Suite 23, Montréal, Québec H1W 4A4,
CA
|
| (54) | BONE TARGETED ALKALINE PHOSPHATASE, KITS AND METHODS OF USE THEREOF |
| BONE TARGETED ALKALINE PHOSPHATASE, KITS AND METHODS OF USE THEREOF |